Concepedia

Publication | Closed Access

B-cell compartment as the selective target for the treatment of immune thrombocytopenias.

97

Citations

13

References

2003

Year

Abstract

Rituximab appears to be a promising immunotherapeutic agent for the treatment of autoimmune thrombocytopenias.

References

YearCitations

Page 1